|
|
| September 22, 2010: Dr. Jean-Philippe Collet discusses the clinical trial CLOVIS-2: A Prospective, Randomized, Nested Case-Control Crossover |
Dr. Jean-Philippe Collet discusses the clinical trial CLOVIS-2: A Prospective, Randomized,
Nested Case-Control Crossover Study of a High vs. Low Clopidogrel Loading Dose in
Clopidogrel Resistant Patients With and Without the CYP2C19*2 Loss-of-Function Allele at
TCT 2010.
Research Grants : BMS-Sanofi Aventis, Eli Lilly, Medtronic, Cordis ,Johnson&Johnson.
Consulting Fees : AstraZeneca, BMS, Daiichi Sankyo, Eli Lilly, Sanofi-Aventis. Lecture
Fees: AstraZeneca, BMS, Daiichi Sankyo, Eli Lilly, and Sanofi-Aventis
[ Download video ] |
|
No comments have been submitted
|